Job offers
There are currently no open job offers.
IP name: Miquel Solà
Contact: Miquel Solà Puig
Job name: Computational design of π-conjugated organic compounds for photovoltaic and optoelectronic applications (COPOA).
Job requirements: a) Not being doctor. b) Have completed sufficient studies to access the doctorate. c) Be pre-registered, accepted, or enrolled in the Chemistry doctoral program at the UdG at the time of application. d) Not having enjoyed predoctoral contracts for more than 12 months at the time of incorporation.
Job contract period: Four years
Incorporation: 1/02/2025
Deadline to apply: 31/10/2024
Job description:
The PhD candidate will investigate using computational tools the fundamental principles of chemical bonding and aromaticity in ground and excited states of ?-conjugated compounds and the application of these principles for the design of the next generation of π-conjugated species for its application in solar cells and OLEDs. Ground and excited state calculations and machine learning procedures will be applied to reach the objective.
IP name: Miquel Solà
Contact: Jordi Mestres
Job name: AI/ML Approaches to Precision Drug Discovery
Job requirements: PhD in chemistry, biology, bioinformatics, biotechnology, or equivalent disciplines with informatics background; good level of programming (Python) and use of notebooks; previous experience with building machine learning models, the management of databases of relevance to drug discovery, the use and development of cheminformatics tools, and the analysis of protein-ligand structural complexes; good level of English is a must
Job contract period: End of the project, 31/8/27
Incorporation: 1/09/2025
Deadline to apply: 31/07/2025
Job description:
The candidate will join the project entitled “An Overarching Approach to Precision Medicine: from Pharmacoproteomics to Pharmacovigilance (PREMED+)”. In particular, the candidate will be taking on the part of the project dedicated to developing novel tools for precision pharmacoproteomics. This will involve methods for protein surface scanning and de novo design of novel bioactive ligands binding to therapeutically-relevant protein mutants.